BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33091670)

  • 1. Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity.
    Gomaa HAM; El-Sherief HAM; Hussein S; Gouda AM; Salem OIA; Alharbi KS; Hayallah AM; Youssif BGM
    Bioorg Chem; 2020 Dec; 105():104369. PubMed ID: 33091670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.
    Ibrahim HS; Eldehna WM; Fallacara AL; Ahmed ER; Ghabbour HA; Elaasser MM; Botta M; Abou-Seri SM; Abdel-Aziz HA
    Future Med Chem; 2018 Dec; 10(24):2771-2789. PubMed ID: 30526032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new pyranoquinolinone heteroannulated to triazolopyrimidine of potential apoptotic antiproliferative activity.
    Ramadan M; Abd El-Aziz M; Elshaier YAMM; Youssif BGM; Brown AB; Fathy HM; Aly AA
    Bioorg Chem; 2020 Dec; 105():104392. PubMed ID: 33137557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiproliferative activity of 8-hydroxyquinoline derivatives containing a 1,2,3-triazole moiety.
    Freitas LB; Borgati TF; de Freitas RP; Ruiz AL; Marchetti GM; de Carvalho JE; da Cunha EF; Ramalho TC; Alves RB
    Eur J Med Chem; 2014 Sep; 84():595-604. PubMed ID: 25062010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
    Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
    Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
    El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents.
    Huang X; Shen QK; Zhang HJ; Li JL; Tian YS; Quan ZS
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic 1,2,3-Triazoles as Potential Leads Targeting the S100A2-p53 Complex: Synthesis and Cytotoxicity.
    Sun J; Baker JR; Russell CC; Cossar PJ; Ngoc Thuy Pham H; Sakoff JA; Scarlett CJ; McCluskey A
    ChemMedChem; 2021 Sep; 16(18):2864-2881. PubMed ID: 34047450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold.
    Li BL; Li B; Zhang RL; Zhao JJ; Wang XF; Liu YM; Shi YP; Liu JB; Chen BQ
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1279-81. PubMed ID: 26786698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity Evaluation.
    Moreira J; Almeida J; Loureiro JB; Ramos H; Palmeira A; Pinto MM; Saraiva L; Cidade H
    ChemMedChem; 2021 Oct; 16(19):2969-2981. PubMed ID: 34170069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents.
    Al-Mahmoudy A; Hassan A; Ibrahim T; Youssif BGM; Taher E; Tantawy M; Abdel-Aal E; Osman N
    Anticancer Agents Med Chem; 2022; 22(5):978-990. PubMed ID: 34126912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.
    Atatreh N; Ghattas MA; Bardaweel SK; Rawashdeh SA; Sorkhy MA
    Drug Des Devel Ther; 2018; 12():3741-3752. PubMed ID: 30464405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
    Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
    Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
    Mohamed MF; Hassaneen HM; Abdelhamid IA
    Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction.
    Zheng GH; Shen JJ; Zhan YC; Yi H; Xue ST; Wang Z; Ji XY; Li ZR
    Eur J Med Chem; 2014 Jun; 81():277-88. PubMed ID: 24852275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitors.
    Pitucha M; Janeczko M; Klimek K; Fornal E; Wos M; Pachuta-Stec A; Ginalska G; Kaczor AA
    Bioorg Chem; 2020 Jun; 99():103806. PubMed ID: 32279038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.